Quote:

---

5 patients on mono for over 4 years

---

I will add: "with no drug resistance" , I believe this is important

Quote:

---

TNBC— Fast Track Designation:

---

I would change for mTNBC, the m for "metastatic" is important.

Quote:

---

MS
Phase 2 IND submission coming early 2020

---

I would add: P2 protocol already finalized by Dr. Dennis Berger following same structure of Biogen's Tysabri